BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 19261447)

  • 21. First detection of plasmid-mediated quinolone resistance in the community setting and in hospitalized patients in Switzerland.
    Liassine N; Zulueta-Rodriguez P; Corbel C; Lascols C; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2008 Nov; 62(5):1151-2. PubMed ID: 18669519
    [No Abstract]   [Full Text] [Related]  

  • 22. [Urinary infections by enterobacteriaceae resistent to antimicrobial agents].
    Ales Reinlein JM; Vela Navarrete R; Fernández Puentes MC; Silva M
    Rev Clin Esp; 1973 Aug; 130(4):295-300. PubMed ID: 4755593
    [No Abstract]   [Full Text] [Related]  

  • 23. Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002-2010.
    Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S1-3. PubMed ID: 22749052
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae strains isolated in North-East Italy.
    Kocsis B; Mazzariol A; Kocsis E; Koncan R; Fontana R; Cornaglia G
    J Chemother; 2013 Feb; 25(1):36-40. PubMed ID: 23433443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro susceptibility of quinolone-resistant Enterobacteriaceae uropathogens to fosfomycin trometamol, in Dakar, Senegal.
    Nabeth P; Perrier-Gros-Claude JD; Juergens-Behr A; Dromigny JA
    Scand J Infect Dis; 2005; 37(6-7):497-9. PubMed ID: 16012011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmid-mediated quinolone resistance in isolates obtained in german intensive care units.
    Jonas D; Biehler K; Hartung D; Spitzmüller B; Daschner FD
    Antimicrob Agents Chemother; 2005 Feb; 49(2):773-5. PubMed ID: 15673764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents.
    Hsu MS; Liao CH; Liu CY; Yang CJ; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2011 Mar; 37(3):276-8. PubMed ID: 21269811
    [No Abstract]   [Full Text] [Related]  

  • 28. Resistance to oral antibiotics in urinary coliform strains isolated between 2000 and 2008 in Sønderborg area, Denmark.
    Cybulski Z; Kjaeldgaard P
    Int J Antimicrob Agents; 2010 May; 35(5):516-7. PubMed ID: 20202798
    [No Abstract]   [Full Text] [Related]  

  • 29. Ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae carrying multiple metallo-beta-lactamase genes.
    Dwivedi M; Mishra A; Azim A; Singh RK; Baronia AK; Prasad KN; Dhole TN; Dwivedi UN
    Indian J Pathol Microbiol; 2009; 52(3):339-42. PubMed ID: 19679955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is plasmid-mediated quinolone resistance a clinically significant problem?
    Poirel L; Cattoir V; Nordmann P
    Clin Microbiol Infect; 2008 Apr; 14(4):295-7. PubMed ID: 18190576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance pattern of enterobacteriaceae isolates from urinary tract infections to selected quinolones in Yaoundé.
    Lyonga EE; Toukam M; Nkenfou C; Gonsu HK; Assoumou MC; Mesembe MT; Eyoh AB; Ikomey GM; Ndze VN; Koulla-Shiro S
    Pan Afr Med J; 2015; 21():105. PubMed ID: 26327943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fosfomycin: an oral agent for urinary infection caused by extended spectrum beta-lactamase producing organisms.
    Hutley EJ; Chand MA; Hounsome G; Kelsey MC
    J Infect; 2010 Apr; 60(4):308-9. PubMed ID: 20114062
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-microbial resistance stratified by risk factor among Escherichia coli strains isolated from the urinary tract at a rural clinic in Central India.
    Chatterjee B; Kulathinal S; Bhargava A; Jain Y; Kataria R
    Indian J Med Microbiol; 2009; 27(4):329-34. PubMed ID: 19736402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiresistant Enterobacteriaceae: new threat of an old problem.
    Pitout JD
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting.
    Leverstein-van Hall MA; Box AT; Blok HE; Paauw A; Fluit AC; Verhoef J
    J Infect Dis; 2002 Jul; 186(1):49-56. PubMed ID: 12089661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Qnr-type quinolone resistance in extended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Coast].
    Guessennd N; Bremont S; Gbonon V; Kacou-Ndouba A; Ekaza E; Lambert T; Dosso M; Courvalin P
    Pathol Biol (Paris); 2008; 56(7-8):439-46. PubMed ID: 18926644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Quinolone Resistance in Enterobacteriaceae from Sierra Leone and the Detection of qnrB Pseudogenes and Modified LexA Binding Sites.
    Leski TA; Stockelman MG; Bangura U; Chae D; Ansumana R; Stenger DA; Vora GJ; Taitt CR
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6920-6923. PubMed ID: 27572395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two chromosomally located qnrB variants, qnrB6 and the new qnrB16, in Citrobacter spp. isolates causing bacteraemia.
    Sanchez-Cespedes J; Marti S; Soto SM; Alba V; Melción C; Almela M; Marco F; Vila J
    Clin Microbiol Infect; 2009 Dec; 15(12):1132-8. PubMed ID: 19392890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmid-mediated quinolone resistance: an update.
    Rodríguez-Martínez JM; Cano ME; Velasco C; Martínez-Martínez L; Pascual A
    J Infect Chemother; 2011 Apr; 17(2):149-82. PubMed ID: 20886256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Infectious drug resistance factors in Enterobacteriaceae producing urinary tract infections].
    Lachmajer M; Bugalski R
    Med Dosw Mikrobiol; 1972; 24(2):95-101. PubMed ID: 5035828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.